Academic Journal
LBA3 Treatment with tumor-infiltrating lymphocytes (TIL) versus ipilimumab for advanced melanoma: Results from a multicenter, randomized phase III trial.
| العنوان: | LBA3 Treatment with tumor-infiltrating lymphocytes (TIL) versus ipilimumab for advanced melanoma: Results from a multicenter, randomized phase III trial. |
|---|---|
| المؤلفون: | Haanen, J.B.A.G.1 (AUTHOR), Rohaan, M.1 (AUTHOR), Borch, T.H.2 (AUTHOR), van den Berg, J.H.3 (AUTHOR), Met, Ö.2 (AUTHOR), Foppen, M. Geukes1 (AUTHOR), Granhøj, J. Stoltenborg2 (AUTHOR), Nuijen, B.4 (AUTHOR), Nijenhuis, C.3 (AUTHOR), Beijnen, J.H.4 (AUTHOR), Jedema, I.5 (AUTHOR), van Zon, M.3 (AUTHOR), Noringriis, I. Mansfield2 (AUTHOR), Kessels, R.6 (AUTHOR), Wilgenhof, S.1 (AUTHOR), van Thienen, H.V.1 (AUTHOR), Lalezari, F.7 (AUTHOR), van Akkooi, A.C.J.8 (AUTHOR), Donia, M.2 (AUTHOR), Svane, I-M.2 (AUTHOR) |
| المصدر: | Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1406-S1406. 1p. |
| مصطلحات موضوعية: | *CLINICAL trials, *TUMOR-infiltrating immune cells, *MELANOMA, *IPILIMUMAB, *THERAPEUTICS |
| قاعدة البيانات: | Academic Search Index |
Full Text Finder | تدمد: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2022.08.036 |